Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of LEVI-04 in Patients With Osteoarthritis of the Knee

NCT05618782 is registered in ClinicalTrials.gov with Levicept as lead sponsor.

NCT NCT05618782
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05618782 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of LEVI-04 in Patients With Osteoarthritis of the Knee
Lead sponsor
Levicept
Phase
Phase 2
Overall status
Completed
Start date
October 19, 2022
Completion date
May 20, 2024
Enrollment
518 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis, joint diseases, knee osteoarthritis, musculoskeletal diseases, osteo arthritis knee, pain, rheumatic diseases